Abstract
It is commonly accepted that the opiate drugs and the enkephalins and endorphins exert their effects by binding to stereospecific receptors on membranes. There appear to be several types of receptor and four main varieties have so far been claimed, κ, σ, δ, and µ (Martin et al., 1976; Lord et al., 1977). Relatively little attention has as yet been paid to what happens after receptor activation. It is usually assumed, although often not explicitly stated, that this activation involves modulation of ion fluxes across the membrane. However, some work suggests that cyclic AMP and prostaglandins may also be involved at the second-messenger level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdulla, Y. H., and Hamadah, K., 1975, Effect of ADP on PGE formation in blood platelets from patients with depression, mania and schizophrenia, Br. J. Psychiatry 127: 591.
Ariens, E. J., Simonis, A. M., and van Rossum, J. M., 1964, Drug—receptor interactions: Interactions of one or more drugs with different receptor systems, in: Molecular Pharmacology: The Mode of Action of Biologically Active Compounds, Vol. 3 ( E. J. Ariens, ed.), pp. 287–393, Academic Press, New York.
Blum, K., Futterman, S., Wallace J. E., and Schwertner, H. A., 1977, Naloxone-induced inhibition of ethanol dependence in mice, Nature (London) 265: 49.
Carlson, L. A., Ekelund, L. G., and Oro, L., 1969, Circulatory and respiratory effects of different doses of PGE, in man, Acta Physiol. Scand. 75: 161.
Collier, H. O. J., and Roy, A. C., 1974, Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenates, Nature (London) 248: 24.
Coupar, I. M., 1978, Inhibition by morphine of prostaglandin-stimulated fluid secretion in rat jejunum, Br. J. Pharmacol. 63: 57.
Diamond, B. I., Handala, H. S., and Borison, R. L., 1977, Potential of lithium as an anaesthetic pre-medicant, Lancet 2: 1229.
Feldberg, W., 1976, Possible association of schizophrenia with a disturbance in prostaglandin metabolism: A physiological hypothesis, Psychol. Med. 6: 359.
Ferri, S., Santagostino, A., Braga, P. C., and Galatulas, I., 1974, Decreased anti-nociceptive effect of morphine in rats treated intraventricularly with prostaglandin E1, Psychopharmacologia 39: 231.
Forlenza, S. W., Axelrod, J. L., and Grieco, M. H., 1979, Pott’s disease in heroin addicts, J. Am. Med. Assoc. 241: 379.
Frenk, H., and McCarty, J. C., 1978, Different brain areas mediate the analgesic and epileptic properties of enkephalin, Science 200: 335.
Goldstein, A., Cox, B. M., Klee, W. A., and Nirenberg, M., 1977, Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma x glioma hybrid cells, Nature (London) 265: 362.
Hamberg, M., Svensson, J., Wakabayashi, T., and Samuelsson, B., 1974, Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation, Proc. Natl. Acad. Sci. USA 71: 345.
Hedqvist, P., 1977, Basic mechanisms of prostaglandin action on autonomic neurotransmission, Annu. Rev. Pharmacol. Toxicol. 17: 259.
Horrobin, D. F., 1977a, Schizophrenia as a prostaglandin deficiency disease, Lancet 1: 936.
Horrobin, D. F., 1977b, Interactions between prostaglandins and calcium: The importance of bell-shaped dose response curves, Prostaglandins 14: 667.
Horrobin, D. F., 1978a, Prostaglandins: Physiology, Pharmacology and Clinical Significance, Churchill Livingstone, Edinburgh.
Horrobin, D. -F., 1978b, Dopamine supersensitivity, endorphin excess and prostaglandin E1 deficiency: Three aspects of the same schizophrenic elephant, Schizophrenia Bull. 4: 487.
Horrobin, D. F., 1979a, Schizophrenia: Reconciliation of the dopamine, prostaglandin and opioid concepts and the role of the pineal, Lancet 1: 529.
Horrobin, D. F., 1979b, Lithium as a regulator of prostaglandin synthesis: Relevance to manic depressive psychosis and schizophrenia and to the mechanism of opiate action, in: Lithium: An International Conference ( T. Cooper, N. S. Kline, and N. Schou, eds.), Excerpta Medica, Amsterdam.
Horrobin, D. F., 1980a, Prostaglandins and schizophrenia, Lancet 1: 706.
Horrobin, D. F., 19806, The regulation of prostaglandin biosynthesis: Negative feedback mechanisms and the selective control of formation of I and 2 series prostaglandins: Relevance to inflammation and immunity, Med. Hypotheses 6: 687.
Horrobin, D. F., 1980c, Lithium as a regulator of prostaglandin synthesis: relevance to manic depressive psychosis and schizophrenia and to the mechanism of opiate action, in: Lithium ( T. Cooper, N. S. Kline, and M. Schou, eds.), pp. 854–880, Excerpta Medica, Amsterdam.
Horrobin, D. F., 1980d, The role of prostaglandin E1 deficiency in schizophrenia: Interactions with dopamine and opiates, in: Biochemistry of Schizophrenia and Addiction ( G. Hemmings, ed.), pp. 3–18, MTP Press, Lancaster.
Horrobin, D. F., and Manku, M. S., 1980, The possible role of prostaglandin E1 in the affective disorders and in alcoholism, Br. Med. J. 1: 1363.
Horrobin, D. F., Durand, L. G., and Manku, M. S., 1977, Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action, Prostaglandins 14: 103.
Horrobin, D. F., Ally, A. I., Karmali, R. A., Karmazyn, M., Manku, M. S., and Morgan, R. O., 1978, Prostaglandins and schizophrenia: Further discussion of the evidence, Psychol. Med. 8: 43.
Horrobin, D. F., Manku, M. S., Oka, M., Morgan, R. O., Cunnane, S. C., Ally, A. I., Ghayur, T., Schweitzer, M., and Karmali, R. A., 1979, The nutritional regulation of T lymphocyte function, Med. Hypotheses 5: 969.
Horton, E. W., 1964, Actions of prostaglandins E1, E2 and E3 on the central nervous system, Br. J. Pharmacol. 22: 189.
Horton, E. W., and Main, I. H. M., 1965, Differences in the effects of prostaglandin F2 alpha, a constituent of cerebral tissue, and prostaglandin E1 in conscious cats and chickens, Int. J. Neuropharmacol. 4: 65.
Jaffe, J. H., and Martin, W. R., 1975, Narcotic analgesics and antagonists, in: The Pharmacological Basis of Therapeutics ( L. S. Goodman and A. Gilman, eds.), 5th ed., pp. 247–283, Macmillan Co., New York.
Janowsky, D., Judd, L., Huey, L., Roitman, N., Parker, D., and Segal, D., 1978, Naloxone effects on manic symptoms and growth hormone levels, Lancet 2: 320.
Jaques, R., 1977, Inhibitory effect of enkephalin on contractions of the guinea pig ileum elicited by PGE1, Agents Actions 7: 317.
Jeffcoate, W. J., Herbert, M., Cullen, M. H., Hastings, A. G., and Walder, C. P., 1979, Prevention of effects of alcohol intoxication by naloxone, Lancet 2: 1157.
Jeffreys, D. B., Flanagan, R. J., and Volans, G. N., 1980, Reversal of ethanol-induced coma with naloxone, Lancet 1: 308.
Jensen, J., 1974, The effect of prolonged lithium ingestion on morphine actions in the rat, Acta Pharmacol. Toxicol. 35: 395.
Leslie, R. D. G., Pyke, D. A., and Stubbs, W. A., 1979, Sensitivity to enkephalin as a cause of non-insulin dependent diabetes, Lancet 1: 341.
Lewis, R. V., Gerber, L. D., Stein, S., Stephen, R. L., Grosser, B. I., Velick, S. F., and Udenfriend, S., 1979, On ßIM-Leu5-endorphin and schizophrenia, Arch. Gen. Psychiatry 36: 237.
Liebman, J. M., 1976, Lithium differentially antagonizes self-stimulation facilitated by morphine and amphetamine, Nature (London) 260: 161.
Lord, J. A. H., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W., 1977, Endogenous opioid peptides: Multiple agonists and receptors, Nature (London) 267: 495.
Mackenzie, A. I., 1979, Naloxone in alcohol intoxication, Lancet 1: 733.
Manku, M. S., Horrobin, D. F., Seidah, N., and Chrétien, M., 1978, Beta-endorphin at physiological concentrations blocks prolactin and zinc-induced synthesis of a prostaglandin El-like substance, Conference on Central Nervous System Effects of Hypothalamic Hormones and Other Peptides, Montreal, May 2.
Manku, M. S., Horrobin, D. F., Karmazyn, M., and Cunnane, S. C., 1979a, Prolactin and zinc effects on rat vascular reactivity: Possible relationship to dihomogammalinolenic acid and to prostaglandin synthesis, Endocrinology 104: 774.
Manku, M. S., Oka, M., and Horrobin, D. F., 1979b, Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. I. Effects of ethanol, Prostaglandins Med. 3: 119.
Manku, M. S., Oka, M., and Horrobin, D. F., 1979c, Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. II. Effects of vitamin C, Prostaglandins Med. 3: 129.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., and Gilbert, P. E., 1976, The effects of morphine-and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther. 197: 517.
Mathé, A. A., Sedvall, G., Wiesel, F. A., and Nyback, H., 1980, Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia, Lancet 1: 16.
Murphy, D. L., Donnelly, C., and Moskovitz, J., 1973, Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets, Clin. Pharmacol. Ther. 14: 810.
Strakosch, C. R., Jefferys, D. B., and Keen, H., 1980, Blockade of chlorpropamide alcohol flush by aspirin, Lancet 1: 394.
Sun, G. Y., and Ho, I. K., 1979, Morphine-induced changes in prostaglandin precursor fatty acids in phospholipids of mouse liver and serum, Life Sci. 24: 751.
Wang, Y. C., Pandey, G. N., Mendels, J., and Frazer, A., 1974, Effect of lithium on prostaglandin El-stimulated adenylate cyclase activity of human platelets, Biochem. Pharmacol. 23: 845.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Horrobin, D.F. (1982). Possible Roles of Prostaglandins in Mediating Opioid Actions. In: Shah, N.S., Donald, A.G. (eds) Endorphins and Opiate Antagonists in Psychiatric Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1119-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1119-5_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1121-8
Online ISBN: 978-1-4684-1119-5
eBook Packages: Springer Book Archive